Back to search

Article

Probabilistic Graphical Models Relate Immune Status with Response to Neoadjuvant Chemo-Therapy in Breast Cancer

2017-10-27

Abstract excerpt

<h4>ABSTRACT</h4> Breast cancer is the most frequent tumor in women and its incidence is increasing. Neoadjuvant chemotherapy has become standard of care as a complement to surgery in locally advanced or poor-prognosis early stage disease. The achievement of a complete response to neoadjuvant chemotherapy correlates with prognosis but it is not possible to predict who will obtain an excellent response. The molecu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd08d593-8424-5bf7-97d4-736494a507cf
DOI
10.1101/210112
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Probabilistic Graphical Models Relate Immune Status with Response to Neoadjuvant Chemo-Therapy in Breast CancerDOI 10.1101/210112
Machine learning models based on immunological genes to predict the response to neoadjuvant therapy in breast cancer patientsSemantic proximity
Predictive factors for response to neoadjuvant therapy in breast cancer.Semantic proximity
Predictive Value of Immune Genomic Signatures from Breast Cancer Cohorts Containing Data for Both Response to Neoadjuvant Chemotherapy and Prognosis after SurgerySemantic proximity
Radiogenomic analysis of the correlation between clinical, ultrasound characteristics and immune-related genes in breast cancerSemantic proximity
Identification of a 10-Gene Signature Model to Predict Efficacy of Neoadjuvant Therapy in Patients With HER2&nbsp;Positive Breast Cancer.Semantic proximity
Machine learning to construct an mRPS risk prognostic model for directing immunotherapy in patients with breast cancer based on the mCAF signature genesSemantic proximity
Drug-Gene Network Signature Modeling Predicts Breast Cancer Patient Response to Neoadjuvant ChemotherapySemantic proximity
Machine Learning for Predicting and Maximizing the Response of Breast Cancer Patients to Neoadjuvant TherapySemantic proximity
CD8-positive T cells are key immune cells for predicting the therapeutic effect of neoadjuvant chemotherapy in triple-negative breast cancerSemantic proximity
RFTN1: an potential inhibitor of the immunity system in TME of breast cancer improving the tumor immune escapeSemantic proximity
FDG-PET/CT and multimodal machine learning model prediction of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancerSemantic proximity
A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast TumorsSemantic proximity
Select a neighboring publication to make it the new centre.